Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Renal Functional Reserve Capacity before and after Living Kidney Donation.

van Londen M, Kasper N, Hessels NR, Messchendorp AL, Bakker SJL, Sanders JF, Berger SP, de Borst MH, Navis G.

Am J Physiol Renal Physiol. 2018 Aug 8. doi: 10.1152/ajprenal.00064.2018. [Epub ahead of print]

PMID:
30089036
2.

Excessive dietary lipid intake provokes an acquired form of lysosomal lipid storage disease in the kidney.

Rampanelli E, Ochodnicky P, Vissers JPC, Butter LM, Claessen N, Calcagni A, Kors L, Gethings LA, Bakker SJL, de Borst MH, Navis GJ, Liebisch G, Speijer D, van den Bergh Weerman MA, Jung B, Aten J, Steenbergen E, Schmitz G, Ballabio A, Florquin S, Aerts JMFG, Leemans JC.

J Pathol. 2018 Aug 2. doi: 10.1002/path.5150. [Epub ahead of print]

PMID:
30073645
3.

Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.

Hanudel MR, Eisenga MF, Rappaport M, Chua K, Qiao B, Jung G, Gabayan V, Gales B, Ramos G, de Jong MA, van Zanden JJ, de Borst MH, Bakker SJL, Nemeth E, Salusky IB, Gaillard CAJM, Ganz T.

Nephrol Dial Transplant. 2018 Jul 10. doi: 10.1093/ndt/gfy189. [Epub ahead of print]

PMID:
30007314
4.

Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease.

Gritter M, Vogt L, Yeung SMH, Wouda RD, Ramakers CRB, de Borst MH, Rotmans JI, Hoorn EJ.

Nephron. 2018 Jun 29:1-10. doi: 10.1159/000490261. [Epub ahead of print]

PMID:
29961059
5.

18F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques.

Hop H, de Boer SA, Reijrink M, Kamphuisen PW, de Borst MH, Pol RA, Zeebregts CJ, Hillebrands JL, Slart RHJA, Boersma HH, Doorduin J, Mulder DJ.

J Nucl Cardiol. 2018 Jun 25. doi: 10.1007/s12350-018-1325-5. [Epub ahead of print]

PMID:
29943142
6.

Magnesium and Blood Pressure: A Physiology-Based Approach.

Schutten JC, Joosten MM, de Borst MH, Bakker SJL.

Adv Chronic Kidney Dis. 2018 May;25(3):244-250. doi: 10.1053/j.ackd.2017.12.003. Review.

PMID:
29793663
7.

Negative effect of vitamin D on kidney function: a Mendelian randomization study.

Teumer A, Gambaro G, Corre T, Bochud M, Vollenweider P, Guessous I, Kleber ME, Delgado GE, Pilz S, März W, Barnes CLK, Joshi PK, Wilson JF, de Borst MH, Navis G, van der Harst P, Heerspink HJL, Homuth G, Endlich K, Nauck M; CKDGen Consortium, Köttgen A, Pattaro C, Ferraro PM.

Nephrol Dial Transplant. 2018 Apr 30. doi: 10.1093/ndt/gfy074. [Epub ahead of print]

PMID:
29718335
8.

Polycyclic Sulfoximines as New Scaffolds for Drug Discovery.

Borst MLG, Ouairy CMJ, Fokkema SC, Cecchi A, Kerckhoffs JMCA, de Boer VL, van den Boogaard PJ, Bus RF, Ebens R, van der Hulst R, Knol J, Libbers R, Lion ZM, Settels BW, de Wever E, Attia KA, Sinnema PJ, de Gooijer JM, Harkema K, Hazewinkel M, Snijder S, Pouwer K.

ACS Comb Sci. 2018 Jun 11;20(6):335-343. doi: 10.1021/acscombsci.7b00150. Epub 2018 May 9.

PMID:
29714998
9.

NPHP1 (Nephrocystin-1) Gene Deletions Cause Adult-Onset ESRD.

Snoek R, van Setten J, Keating BJ, Israni AK, Jacobson PA, Oetting WS, Matas AJ, Mannon RB, Zhang Z, Zhang W, Hao K, Murphy B, Reindl-Schwaighofer R, Heinzl A, Oberbauer R, Viklicky O, Conlon PJ, Stapleton CP, Bakker SJL, Snieder H, Peters EDJ, van der Zwaag B, Knoers NVAM, de Borst MH, van Eerde AM.

J Am Soc Nephrol. 2018 Jun;29(6):1772-1779. doi: 10.1681/ASN.2017111200. Epub 2018 Apr 13.

PMID:
29654215
10.

Performances of metal concentrations from three permeable pavement infiltrates.

Liu J, Borst M.

Water Res. 2018 Jun 1;136:41-53. doi: 10.1016/j.watres.2018.02.050. Epub 2018 Feb 21.

PMID:
29499428
11.

Estimated glomerular filtration rate for longitudinal follow-up of living kidney donors.

van Londen M, Wijninga AB, de Vries J, Sanders JF, de Jong MFC, Pol RA, Berger SP, Navis G, de Borst MH.

Nephrol Dial Transplant. 2018 Jun 1;33(6):1054-1064. doi: 10.1093/ndt/gfx370.

PMID:
29481686
12.

Dietary Approach to Stop Hypertension (DASH) diet and risk of renal function decline and all-cause mortality in renal transplant recipients.

Osté MCJ, Gomes-Neto AW, Corpeleijn E, Gans ROB, de Borst MH, van den Berg E, Soedamah-Muthu SS, Kromhout D, Navis GJ, Bakker SJL.

Am J Transplant. 2018 Feb 21. doi: 10.1111/ajt.14707. [Epub ahead of print]

PMID:
29464830
13.

Overweight young female kidney donors have low renal functional reserve post-donation.

van Londen M, Schaeffers AWMA, de Borst MH, Joles JA, Navis G, Lely AT.

Am J Physiol Renal Physiol. 2018 Jan 3. doi: 10.1152/ajprenal.00492.2017. [Epub ahead of print]

PMID:
29357424
14.

Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General Population.

Taylor JM, Kieneker LM, de Borst MH, Visser ST, Kema IP, Bakker SJL, Gansevoort RT.

Kidney Int Rep. 2016 Dec 31;2(3):366-379. doi: 10.1016/j.ekir.2016.12.007. eCollection 2017 May.

15.

Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.

Ter Maaten JM, Voors AA, Damman K, van der Meer P, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Navis G, Ng L, Ouwerkerk W, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, de Borst MH.

Int J Cardiol. 2018 Feb 15;253:84-90. doi: 10.1016/j.ijcard.2017.10.010.

16.

Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study.

Riphagen IJ, Keyzer CA, Drummen NEA, de Borst MH, Beulens JWJ, Gansevoort RT, Geleijnse JM, Muskiet FAJ, Navis G, Visser ST, Vermeer C, Kema IP, Bakker SJL.

Nutrients. 2017 Dec 8;9(12). pii: E1334. doi: 10.3390/nu9121334.

17.

Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.

de Borst MH, Baia LC, Hoogeveen EK, Giltay EJ, Navis G, Bakker SJL, Geleijnse JM, Kromhout D, Soedamah-Muthu SS.

Nutrients. 2017 Nov 11;9(11). pii: E1233. doi: 10.3390/nu9111233.

18.

Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.

Parvanova A, Trillini M, Podestà MA, Iliev IP, Ruggiero B, Abbate M, Perna A, Peraro F, Diadei O, Rubis N, Gaspari F, Carrara F, Stucchi N, Belviso A, Bossi AC, Trevisan R, Remuzzi G, de Borst M, Ruggenenti P; PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016.

Lancet Diabetes Endocrinol. 2018 Jan;6(1):27-40. doi: 10.1016/S2213-8587(17)30359-5. Epub 2017 Nov 2.

PMID:
29104158
19.

Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention.

Petrykiv SI, Laverman GD, Persson F, Vogt L, Rossing P, de Borst MH, Gansevoort RT, de Zeeuw D, Heerspink HJL.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1804-1813. doi: 10.2215/CJN.00390117. Epub 2017 Oct 11. Review.

PMID:
29021336
20.

Tubular maximum phosphate reabsorption capacity in living kidney donors is independently associated with one-year recipient GFR.

van Londen M, Aarts BM, Sanders JS, Hillebrands JL, Bakker SJL, Navis G, de Borst MH.

Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F196-F202. doi: 10.1152/ajprenal.00287.2017. Epub 2017 Oct 4.

PMID:
28978532
21.

C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.

Eisenga MF, van Londen M, Leaf DE, Nolte IM, Navis G, Bakker SJL, de Borst MH, Gaillard CAJM.

J Am Soc Nephrol. 2017 Dec;28(12):3639-3646. doi: 10.1681/ASN.2016121350. Epub 2017 Aug 3.

PMID:
28774998
22.

Public health relevance of drug-nutrition interactions.

Péter S, Navis G, de Borst MH, von Schacky C, van Orten-Luiten ACB, Zhernakova A, Witkamp RF, Janse A, Weber P, Bakker SJL, Eggersdorfer M.

Eur J Nutr. 2017 Aug;56(Suppl 2):23-36. doi: 10.1007/s00394-017-1510-3.

23.

Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney.

Wain LV, Vaez A, Jansen R, Joehanes R, van der Most PJ, Erzurumluoglu AM, O'Reilly PF, Cabrera CP, Warren HR, Rose LM, Verwoert GC, Hottenga JJ, Strawbridge RJ, Esko T, Arking DE, Hwang SJ, Guo X, Kutalik Z, Trompet S, Shrine N, Teumer A, Ried JS, Bis JC, Smith AV, Amin N, Nolte IM, Lyytikäinen LP, Mahajan A, Wareham NJ, Hofer E, Joshi PK, Kristiansson K, Traglia M, Havulinna AS, Goel A, Nalls MA, Sõber S, Vuckovic D, Luan J, Del Greco M F, Ayers KL, Marrugat J, Ruggiero D, Lopez LM, Niiranen T, Enroth S, Jackson AU, Nelson CP, Huffman JE, Zhang W, Marten J, Gandin I, Harris SE, Zemunik T, Lu Y, Evangelou E, Shah N, de Borst MH, Mangino M, Prins BP, Campbell A, Li-Gao R, Chauhan G, Oldmeadow C, Abecasis G, Abedi M, Barbieri CM, Barnes MR, Batini C, Beilby J, Blake T, Boehnke M, Bottinger EP, Braund PS, Brown M, Brumat M, Campbell H, Chambers JC, Cocca M, Collins F, Connell J, Cordell HJ, Damman JJ, Davies G, de Geus EJ, de Mutsert R, Deelen J, Demirkale Y, Doney ASF, Dörr M, Farrall M, Ferreira T, Frånberg M, Gao H, Giedraitis V, Gieger C, Giulianini F, Gow AJ, Hamsten A, Harris TB, Hofman A, Holliday EG, Hui J, Jarvelin MR, Johansson Å, Johnson AD, Jousilahti P, Jula A, Kähönen M, Kathiresan S, Khaw KT, Kolcic I, Koskinen S, Langenberg C, Larson M, Launer LJ, Lehne B, Liewald DCM, Lin L, Lind L, Mach F, Mamasoula C, Menni C, Mifsud B, Milaneschi Y, Morgan A, Morris AD, Morrison AC, Munson PJ, Nandakumar P, Nguyen QT, Nutile T, Oldehinkel AJ, Oostra BA, Org E, Padmanabhan S, Palotie A, Paré G, Pattie A, Penninx BWJH, Poulter N, Pramstaller PP, Raitakari OT, Ren M, Rice K, Ridker PM, Riese H, Ripatti S, Robino A, Rotter JI, Rudan I, Saba Y, Saint Pierre A, Sala CF, Sarin AP, Schmidt R, Scott R, Seelen MA, Shields DC, Siscovick D, Sorice R, Stanton A, Stott DJ, Sundström J, Swertz M, Taylor KD, Thom S, Tzoulaki I, Tzourio C, Uitterlinden AG, Völker U, Vollenweider P, Wild S, Willemsen G, Wright AF, Yao J, Thériault S, Conen D, Attia J, Sever P, Debette S, Mook-Kanamori DO, Zeggini E, Spector TD, van der Harst P, Palmer CNA, Vergnaud AC, Loos RJF, Polasek O, Starr JM, Girotto G, Hayward C, Kooner JS, Lindgren CM, Vitart V, Samani NJ, Tuomilehto J, Gyllensten U, Knekt P, Deary IJ, Ciullo M, Elosua R, Keavney BD, Hicks AA, Scott RA, Gasparini P, Laan M, Liu Y, Watkins H, Hartman CA, Salomaa V, Toniolo D, Perola M, Wilson JF, Schmidt H, Zhao JH, Lehtimäki T, van Duijn CM, Gudnason V, Psaty BM, Peters A, Rettig R, James A, Jukema JW, Strachan DP, Palmas W, Metspalu A, Ingelsson E, Boomsma DI, Franco OH, Bochud M, Newton-Cheh C, Munroe PB, Elliott P, Chasman DI, Chakravarti A, Knight J, Morris AP, Levy D, Tobin MD, Snieder H, Caulfield MJ, Ehret GB.

Hypertension. 2017 Jul 24. pii: HYPERTENSIONAHA.117.09438. doi: 10.1161/HYPERTENSIONAHA.117.09438. [Epub ahead of print]

24.

Biomarkers of Renal Function: Towards Clinical Actionability.

Binnenmars SH, Hijmans RS, Navis G, de Borst MH.

Clin Pharmacol Ther. 2017 Sep;102(3):481-492. doi: 10.1002/cpt.765. Epub 2017 Jul 21. Review.

PMID:
28608458
25.

Corrigendum: 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function.

Gorski M, Most PJV, Teumer A, Chu AY, Li M, Mijatovic V, Nolte IM, Cocca M, Taliun D, Gomez F, Li Y, Tayo B, Tin A, Feitosa MF, Aspelund T, Attia J, Biffar R, Bochud M, Boerwinkle E, Borecki I, Bottinger EP, Chen MH, Chouraki V, Ciullo M, Coresh J, Cornelis MC, Curhan GC, Adamo AP, Dehghan A, Dengler L, Ding J, Eiriksdottir G, Endlich K, Enroth S, Esko T, Franco OH, Gasparini P, Gieger C, Girotto G, Gottesman O, Gudnason V, Gyllensten U, Hancock SJ, Harris TB, Helmer C, Höllerer S, Hofer E, Hofman A, Holliday EG, Homuth G, Hu FB, Huth C, Hutri-Kähönen N, Hwang SJ, Imboden M, Johansson Å, Kähönen M, König W, Kramer H, Krämer BK, Kumar A, Kutalik Z, Lambert JC, Launer LJ, Lehtimäki T, de Borst MH, Navis G, Swertz M, Liu Y, Lohman K, Loos RJF, Lu Y, Lyytikäinen LP, McEvoy MA, Meisinger C, Meitinger T, Metspalu A, Metzger M, Mihailov E, Mitchell P, Nauck M, Oldehinkel AJ, Olden M, Wjh Penninx B, Pistis G, Pramstaller PP, Probst-Hensch N, Raitakari OT, Rettig R, Ridker PM, Rivadeneira F, Robino A, Rosas SE, Ruderfer D, Ruggiero D, Saba Y, Sala C, Schmidt H, Schmidt R, Scott RJ, Sedaghat S, Smith AV, Sorice R, Stengel B, Stracke S, Strauch K, Toniolo D, Uitterlinden AG, Ulivi S, Viikari JS, Völker U, Vollenweider P, Völzke H, Vuckovic D, Waldenberger M, Wang JJ, Yang Q, Chasman DI, Tromp G, Snieder H, Heid IM, Fox CS, Köttgen A, Pattaro C, Böger CA, Fuchsberger C.

Sci Rep. 2017 May 26;7:46835. doi: 10.1038/srep46835.

26.

Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.

van Londen M, Aarts BM, Deetman PE, van der Weijden J, Eisenga MF, Navis G, Bakker SJL, de Borst MH; NIGRAM Consortium.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1301-1310. doi: 10.2215/CJN.10270916. Epub 2017 May 25.

27.

1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function.

Gorski M, van der Most PJ, Teumer A, Chu AY, Li M, Mijatovic V, Nolte IM, Cocca M, Taliun D, Gomez F, Li Y, Tayo B, Tin A, Feitosa MF, Aspelund T, Attia J, Biffar R, Bochud M, Boerwinkle E, Borecki I, Bottinger EP, Chen MH, Chouraki V, Ciullo M, Coresh J, Cornelis MC, Curhan GC, d'Adamo AP, Dehghan A, Dengler L, Ding J, Eiriksdottir G, Endlich K, Enroth S, Esko T, Franco OH, Gasparini P, Gieger C, Girotto G, Gottesman O, Gudnason V, Gyllensten U, Hancock SJ, Harris TB, Helmer C, Höllerer S, Hofer E, Hofman A, Holliday EG, Homuth G, Hu FB, Huth C, Hutri-Kähönen N, Hwang SJ, Imboden M, Johansson Å, Kähönen M, König W, Kramer H, Krämer BK, Kumar A, Kutalik Z, Lambert JC, Launer LJ, Lehtimäki T, de Borst M, Navis G, Swertz M, Liu Y, Lohman K, Loos RJF, Lu Y, Lyytikäinen LP, McEvoy MA, Meisinger C, Meitinger T, Metspalu A, Metzger M, Mihailov E, Mitchell P, Nauck M, Oldehinkel AJ, Olden M, Wjh Penninx B, Pistis G, Pramstaller PP, Probst-Hensch N, Raitakari OT, Rettig R, Ridker PM, Rivadeneira F, Robino A, Rosas SE, Ruderfer D, Ruggiero D, Saba Y, Sala C, Schmidt H, Schmidt R, Scott RJ, Sedaghat S, Smith AV, Sorice R, Stengel B, Stracke S, Strauch K, Toniolo D, Uitterlinden AG, Ulivi S, Viikari JS, Völker U, Vollenweider P, Völzke H, Vuckovic D, Waldenberger M, Jin Wang J, Yang Q, Chasman DI, Tromp G, Snieder H, Heid IM, Fox CS, Köttgen A, Pattaro C, Böger CA, Fuchsberger C.

Sci Rep. 2017 Apr 28;7:45040. doi: 10.1038/srep45040. Erratum in: Sci Rep. 2017 May 26;7:46835. de Borst, Martin H [corrected to de Borst, Martin].

28.

Low plasma homoarginine concentration is associated with high rates of all-cause mortality in renal transplant recipients.

Kayacelebi AA, Minović I, Hanff E, Frenay AS, de Borst MH, Feelisch M, van Goor H, Bakker SJL, Tsikas D.

Amino Acids. 2017 Jul;49(7):1193-1202. doi: 10.1007/s00726-017-2420-7. Epub 2017 Apr 20.

PMID:
28429125
29.

Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review.

van der Plas WY, Dulfer RR, Engelsman AF, Vogt L, de Borst MH, van Ginhoven TM, Kruijff S; Dutch Hyperparathryoid Study Group (DHSG).

Nephrol Dial Transplant. 2017 Nov 1;32(11):1902-1908. doi: 10.1093/ndt/gfx044. Review.

PMID:
28402557
30.

NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality.

Böger CA, Gorski M, McMahon GM, Xu H, Chang YC, van der Most PJ, Navis G, Nolte IM, de Borst MH, Zhang W, Lehne B, Loh M, Tan ST, Boerwinkle E, Grams ME, Sekula P, Li M, Wilmot B, Moon JG, Scheet P, Cucca F, Xiao X, Lyytikäinen LP, Delgado G, Grammer TB, Kleber ME, Sedaghat S, Rivadeneira F, Corre T, Kutalik Z, Bergmann S, Nielson CM, Srikanth P, Teumer A, Müller-Nurasyid M, Brockhaus AC, Pfeufer A, Rathmann W, Peters A, Matsumoto M, de Andrade M, Atkinson EJ, Robinson-Cohen C, de Boer IH, Hwang SJ, Heid IM, Gögele M, Concas MP, Tanaka T, Bandinelli S, Nalls MA, Singleton A, Tajuddin SM, Adeyemo A, Zhou J, Doumatey A, McWeeney S, Murabito J, Franceschini N, Flessner M, Shlipak M, Wilson JG, Chen G, Rotimi CN, Zonderman AB, Evans MK, Ferrucci L, Devuyst O, Pirastu M, Shuldiner A, Hicks AA, Pramstaller PP, Kestenbaum B, Kardia SLR, Turner ST, Study LC, Briske TE, Gieger C, Strauch K, Meisinger C, Meitinger T, Völker U, Nauck M, Völzke H, Vollenweider P, Bochud M, Waeber G, Kähönen M, Lehtimäki T, März W, Dehghan A, Franco OH, Uitterlinden AG, Hofman A, Taylor HA, Chambers JC, Kooner JS, Fox CS, Hitzemann R, Orwoll ES, Pattaro C, Schlessinger D, Köttgen A, Snieder H, Parsa A, Cohen DM.

J Am Soc Nephrol. 2017 Aug;28(8):2311-2321. doi: 10.1681/ASN.2016080892. Epub 2017 Mar 30.

31.

Vitamin D inhibits lymphangiogenesis through VDR-dependent mechanisms.

Yazdani S, Poosti F, Toro L, Wedel J, Mencke R, Mirković K, de Borst MH, Alexander JS, Navis G, van Goor H, van den Born J, Hillebrands JL.

Sci Rep. 2017 Mar 17;7:44403. doi: 10.1038/srep44403.

32.

Mediterranean style diet is associated with low risk of new-onset diabetes after renal transplantation.

Osté MC, Corpeleijn E, Navis GJ, Keyzer CA, Soedamah-Muthu SS, van den Berg E, Postmus D, de Borst MH, Kromhout D, Bakker SJ.

BMJ Open Diabetes Res Care. 2017 Jan 13;5(1):e000283. doi: 10.1136/bmjdrc-2016-000283. eCollection 2017.

33.

Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.

Humalda JK, Seiler-Muler S, Kwakernaak AJ, Vervloet MG, Navis G, Fliser D, Heine GH, de Borst MH.

Medicine (Baltimore). 2016 Nov;95(46):e5003.

34.

Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial.

Keyzer CA, van Breda GF, Vervloet MG, de Jong MA, Laverman GD, Hemmelder MH, Janssen WM, Lambers Heerspink HJ, Kwakernaak AJ, Bakker SJ, Navis G, de Borst MH; Holland Nephrology Study (HONEST) Network.

J Am Soc Nephrol. 2017 Apr;28(4):1296-1305. doi: 10.1681/ASN.2016040407. Epub 2016 Nov 17.

35.

Serum free sulfhydryl status is associated with patient and graft survival in renal transplant recipients.

Frenay AS, de Borst MH, Bachtler M, Tschopp N, Keyzer CA, van den Berg E, Bakker SJL, Feelisch M, Pasch A, van Goor H.

Free Radic Biol Med. 2016 Oct;99:345-351. doi: 10.1016/j.freeradbiomed.2016.08.024. Epub 2016 Aug 20.

PMID:
27554970
36.

Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice.

Poosti F, Bansal R, Yazdani S, Prakash J, Beljaars L, van den Born J, de Borst MH, van Goor H, Hillebrands JL, Poelstra K.

Oncotarget. 2016 Aug 23;7(34):54240-54252. doi: 10.18632/oncotarget.11095.

37.

Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism.

van der Plas WY, Engelsman AF, Özyilmaz A, van der Horst-Schrivers AN, Meijer K, van Dam GM, Pol RA, de Borst MH, Kruijff S.

Ann Surg Oncol. 2017 Jan;24(1):15-22. doi: 10.1245/s10434-016-5450-6. Epub 2016 Jul 26.

38.

Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT).

Adema AY, de Jong MA, de Borst MH, Ter Wee PM, Vervloet MG; NIGRAM Consortium.

Nephron. 2016;134(4):215-220. Epub 2016 Jul 22.

39.

Concordance of dietary sodium intake and concomitant phosphate load: Implications for sodium interventions.

Humalda JK, Keyzer CA, Binnenmars SH, Kwakernaak AJ, Slagman MC, Laverman GD, Bakker SJ, de Borst MH, Navis GJ.

Nutr Metab Cardiovasc Dis. 2016 Aug;26(8):689-96. doi: 10.1016/j.numecd.2016.04.012. Epub 2016 Apr 27.

PMID:
27266988
40.

Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis.

de Jong MA, Mirkovic K, Mencke R, Hoenderop JG, Bindels RJ, Vervloet MG, Hillebrands JL, van den Born J, Navis G, de Borst MH; NIGRAM consortium.

Nephrol Dial Transplant. 2017 Jan 1;32(1):73-80. doi: 10.1093/ndt/gfw105.

PMID:
27220755
41.

Tumor Necrosis Factor α Blockade to Ameliorate Renal ischemia Reperfusion Injury: Potential Implications for Kidney Transplantation.

Moers C, Pol RA, de Borst MH.

Transplantation. 2016 Aug;100(8):1601-2. doi: 10.1097/TP.0000000000001221. No abstract available.

PMID:
27163537
42.

Sodium intake, RAAS-blockade and progressive renal disease.

de Borst MH, Navis G.

Pharmacol Res. 2016 May;107:344-351. doi: 10.1016/j.phrs.2016.03.037. Epub 2016 Mar 31. Review.

PMID:
27041482
43.

Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating α-Klotho Concentrations.

Adema AY, van Ittersum FJ, Hoenderop JG, de Borst MH, Nanayakkara PW, Ter Wee PM, Heijboer AC, Vervloet MG; NIGRAM consortium.

PLoS One. 2016 Jan 25;11(1):e0144121. doi: 10.1371/journal.pone.0144121. eCollection 2016.

44.

The Complement System in Hemodialysis Patients: Getting to the Heart of the Matter.

de Borst MH.

Nephron. 2016;132(1):1-4. doi: 10.1159/000443340. Epub 2016 Jan 9. No abstract available.

45.

Measurement of plasma vitamin K1 (phylloquinone) and K2 (menaquinones-4 and -7) using HPLC-tandem mass spectrometry.

Riphagen IJ, van der Molen JC, van Faassen M, Navis G, de Borst MH, Muskiet FA, de Jong WH, Bakker SJ, Kema IP.

Clin Chem Lab Med. 2016 Jul 1;54(7):1201-10. doi: 10.1515/cclm-2015-0864.

PMID:
26630696
47.

Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis.

Humalda JK, Riphagen IJ, Assa S, Hummel YM, Westerhuis R, Vervloet MG, Voors AA, Navis G, Franssen CF, de Borst MH; NIGRAM Consortium.

Nephrol Dial Transplant. 2016 Sep;31(9):1494-501. doi: 10.1093/ndt/gfv393. Epub 2015 Nov 24.

PMID:
26602863
48.

Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.

Dietrich CF, Annema JT, Clementsen P, Cui XW, Borst MM, Jenssen C.

J Thorac Dis. 2015 Sep;7(9):E311-25. doi: 10.3978/j.issn.2072-1439.2015.09.40. Review.

49.

Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.

Keyzer CA, Lambers-Heerspink HJ, Joosten MM, Deetman PE, Gansevoort RT, Navis G, Kema IP, de Zeeuw D, Bakker SJ, de Borst MH; PREVEND Study Group.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2119-27. doi: 10.2215/CJN.03830415. Epub 2015 Oct 8.

50.

Toll-Like Receptor Family Polymorphisms Are Associated with Primary Renal Diseases but Not with Renal Outcomes Following Kidney Transplantation.

Dessing MC, Kers J, Damman J, Leuvenink HG, van Goor H, Hillebrands JL, Hepkema BG, Snieder H, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Florquin S, Seelen M, Leemans JC.

PLoS One. 2015 Oct 7;10(10):e0139769. doi: 10.1371/journal.pone.0139769. eCollection 2015.

Supplemental Content

Support Center